Article
22 Jan 2026
Year In Review: Top Legal Developments Of 2025
AUTHORS CONTENT
Article
29 Dec 2025
Vertex Presents New CASGEVY® Data In Patients 5-11 Years And Announces Plan For Global Regulatory Submissions
Article
14 Oct 2025
Celltrion Announces Launch Of AVTOZMA® (Tocilizumab-anoh) Intravenous Formulation In The United States
Article
07 Aug 2025
European Biosimilar Updates – Formycon's Ustekinumab And Alvotech's Cetrolizumab Pegol
Article
01 Jul 2025
BioNTech Announces Transaction To Acquire CureVac
Article
27 May 2025
FDA Approves BLA For Novavax's COVID-19 Vaccine
Article
20 Mar 2025
FDA Approves Celltrion's OMLYCLO® (Omalizumab-igec)
Article
11 Feb 2025
BioNTech Acquires Biotheus To Boost Oncology Strategy
Article
19 Dec 2024
Intas Expands Cancer Therapy Biosimilar Portfolio
Article
11 Nov 2024
EMA Accepts Marketing Authorization Application For Alvotech's AVT05 (Golimumab)
Article
14 Oct 2024
Fresenius And Formycon Receive EC And FDA Approval Of Ustekinumab Biosimilar
Article
29 Jul 2024
STADA And Alvotech Announce Launch Of UZPROVO® In Europe
Article
02 Jul 2024
Update On John Hopkins And Merck Pembrolizumab Litigation